Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001847903-24-000182
Filing Date
2024-12-17
Accepted
2024-12-17 17:09:02
Documents
1
Period of Report
2024-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1734473335.html 4  
1 FORM 4 wk-form4_1734473335.xml 4 13088
  Complete submission text file 0001847903-24-000182.txt   14719
Mailing Address C/O CENTESSA PHARMACEUTICALS PLC 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM CHESHIRE X0 WA14 2DT
Business Address
Anderson Karen M. (Reporting) CIK: 0001762176 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40445 | Film No.: 241556616

Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Issuer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)